3 days. The effect of 1 .25(OH),D3 on virus production was also blocked by anti-TNF antibodies, which suggests the direct participation of TNF in this process. TNF accumulated in the culture supernatant of cells stimulated with ONOCYTES AND macrophages as well as helper T
M lymphocytes are important target cells for human immunodeficiency virus type 1 (HIV-
Whereas T lymphocytes tend to be destroyed after infection, monocytes and macrophages harbor the virus without induction of a cytolytic effect, and they may constitute a major reservoir for the virus in humans.'@I3 Serum concentrations oftumor necrosis factor alpha (TNF-a) are elevated in patients with HIV disease, especially in advanced stage^,'^.'^ and TNF-a is believed to play a role in the pathogenesis in HIV infection by upregulating viral expression in macrophages and T lymphocyte^.'^^'^ In vitro, TNF-a has been shown to enhance HIV replication in mononuclear phagocytes and infected T-cell lines, and the effect of TNF-a on HIV replication is correlated with increased binding ofthe transcription factor NFKB to the HIV long terminal Moreover, an autocrine role for TNF-a has been demonstrated in the 1 ,25(OH),D3 with a kinetics consistent with its involvement in the action of 1 ,25(OH),D3 on viral production. The J2,-HL-60 cell line produced low levels of virus when cultured in the absence of an external stimulus; however, this basal viral production was suppressed greater than 80% in the presence of anti-TNF antibodies. Corresponding low levels of TNF were detected in the culture supernatants. Viral production decreased slowly with increasing passage of the cells, and no virus was detected in the supernatants of cells maintained in culture for several months. Concomitantly, TNF was no longer detected in the supernatant of these cells, which suggests that endogenous autocrine production of TNF drives viral production in the unstimulated cells. However, viral production was stimulated in these cells by low concentrations (0.1 ng/mL) of added TNF. These results argue for a central role for TNF in HIV proviral activation in chronically infected myeloid cells. induction of HIV expression in monocytic cell lines,28p29 T-lymphocyte and peripheral blood mononuclear cells.31 It has also been described that TNF-a autoinduces expression of TNF-a in HL-60 ~e l l s .~~, ~~ We have shown that certain myelomonocytic cell lines became susceptible to infection by monocytotropic HIV strains when they were induced to differentiation with 1,25-dihydroxyvitamin D3 ( 1 ,25[OH],D3), 12-0-tetradecanoylphorbol-13-acetate (TPA), or retinoic acid.34 However, it was not clear whether acquisition of HIV infectivity was caused by factors associated with cell differentiation or caused by direct effects of the inducer itself. Laboratorymaintained strains of HIV such as HTLV-IIIB readily infected HL-60 cells; however, it was difficult to infect these cells with primary viral isolates. We established a chronically HIV-infected HL-60 cell line and derived a clone, J22-HL-60, which contains one copy of the monocytotropic HIV-l,R.m provirus. 34 The precise involvement of HIV in myelopoiesis is uncertain, and recent attempts to identify virus in granulocyte/monocyte colony-forming cells from infected individuals has not provided evidence for infection of these bone marrow progenitor^.^^ Although hematopoietic stem cells may be infectable in vitro with HIV,8,36 there is as yet no direct evidence for stem cell infection in vivo. Although the J2,-HL-60 cell line does not model a known human HIV reservoir, it is useful for examining signaling pathways for HIV production in a precursor myeloid cell capable of granulocytic and monocytic differentiation. We report here an autocrine role for TNF-a in viral production by this cell line and provide evidence that TNF-a may mediate the proviral activation associated with I ,25(OH),D3 exposure. Our data indicate that in the absence of endogenous and exogenous TNF, there is no production of HIV by JZ2-HL-60 cells.
MATERIALS AND METHODS
The establishment of a HL-60 cell line (J,,-HL-60) infected with a monocytotropic strain of HIV-l,R-m and containing a Cells. 1,25(OH),D,, TPA, and 3'-azido-3'-deoxythymidine (AZT) were all purchased from Sigma Chemical CO (St Louis, MO). A polyclonal anti-human TNF-a neutralizing antibody (raised in goats, affinity purified IgG fraction) was obtained from R&D Systems. This antibody, at a concentration of I pg/mL, inhibits 100% of the biologic activity of 0.25 ng/mL of TNF-a. A second anti-TNF-a antibody obtained from Boehringer-Mannheim Corporation (Indianapolis, IN) was also used in some of the experiments. A polyclonal anti-murine interleukin-5 (IL-5) neutralizing antibody (raised in goats, affinity purified IgG fraction) was used as a control. This antibody does not cross react with human TNF-a. Stock solutions of 1,25(OH)*D3 were prepared in 100% ethanol and stored at -70°C. The final concentration of ethanol in the cultures never exceeded 0.1% (vol/vol), which had no effect on cell viability (as measured by exclusion of trypan blue), cell proliferation, or viral production.
Virus measurement. To measure virus production, I x lo5 JZz-HL-60 cells were cultured under the conditions described (Figs 1-7) . Cell culture supernatants were assayed for the presence of HIV p24 core antigen using a commercially available p24 capture enzymelinked immunosorbent assay (ELISA) kit (Coulter HIV-1 p24 antigen assay and Coulter HIV-1 p24 antigen kinetic standard; Coulter Corp, Hialeah, FL). TNF-a was measured in cell culture su-TNF-a measurement. pernatants using a commercially available ELISA kit (R&D Systems).
RESULTS
When J,,-HL-60 cells were cultured in the presence of 1 ng/mL of TNF-a for varied periods of time, a major increase in viral production was observed as compared with control cells (Fig 1A) . As a positive control for viral production, J,,-HL-60 cells were stimulated with TPA. Viral production induced by TNF-a was quantitatively equivalent to that induced by a maximally stimulatory concentration ( 1 pmol/L) of TPA ( Fig 1A) . The kinetics of accumulation of virus in the cell culture supernatants was also similar for the two agents, with maximal accumulation observed 24 hours after initiating the culture (Fig 1A) . These studies indicated that J,,-HL-60 cells were highly sensitive to the action of TNF-a, with a substantial increase in viral production observed at concentrations of TNF-a as low as 30 pg/mL ( Fig  IB) . Maximal viral production was observed at 100 pg/mL, with a 50% effective dose (ED,,) ofabout 60 pg/mL. Further studies indicated that the kinetics of viral production was similar for all concentrations of TNF-a tested, from 0.1 to 30.0 ng/mL (data not shown). Similar results were observed with TPA at concentrations ranging from 0.3 to 100.0 pmol/L (data not shown). To test for the specificity of TNFa action, cells were incubated in the presence of both maximally stimulatory concentrations of TNF-a and blocking TNF-a antibodies. As expected, TNF-a-induced viral production was specifically and totally suppressed by the anti-TNF antibodies (Fig 2A) . At least two other different TNFa antibodies were used in these experiments with similar For personal use only. on October 3, 2017. by guest www.bloodjournal.org From results (data not shown). A potential problem with these experiments was the possibility that the TNF-(U antibodies present in the samples could interfere with the capture ELlSA system used for the quantitation of the HIV p24 core antigen. A control experiment was performed in which different antibodies were added to a culture supernatant containing known amounts of exogenously added HIV p24 core antigen. As can be seen in Fig 2B. the presence of the antibodies did not affect the quantitative determination of the HIV p24 core antigen, which confirmed the specificity of the inhibitory activity of the anti-TNF-n antibodies on viral production.
AZT was used to test for superinfection in cells cultured in the presence of TNF-a. As shown in Fig 3A. AZT did not affect viral production induced by TNF-n, ruling out the possibility of further production of virus through the active superinfection of cells during the experiment. This was an important control, because the J2,-HL-60 cells replicated actively over the course of the experiment, with a doubling time of about I8 hours (Fig 3B) . No effect of TNF-a on cell viability (data not shown) or cell proliferation (Fig 3B) was observed in these experiments relative to control cells cultured in the presence of medium alone. At the concentrations used AZT did not affect cell proliferation. as assessed by thymidine uptake experiments (data not shown).
I .25(OH),D3 isa well-known differentiatingagent for myeloid cells,3s and shows effects similar to TNF-n on the differentiation of HL-60 cell^.^^.^^"' No viral production was observed during the first 2 days of culture (Fig 4A) when J2,-HL-60 cells were incubated in the presence of 1.25(OH),D3. Viral accumulation was only evident after 3 days of incubation and reached final levels somewhat lower than those observed in cells stimulated with TNF-a. The delayed kinetics of I .25(OH),D3-induced viral production contrasted with the detection of significant amounts of viral particles in the culture supernatants in the first 8 hours after stimulation with TNF-n ( Fig 4B) . In studies of the dose TB;_. Cell number was determined at 1,2,3,4 , 5, and 6 days.
dependence of viral production, I ,25(OH),D3 at 0.1 pmol/ L induced substantial accumulation of virus in the culture supernatants (Fig 4C) . Maximal virus production was observed at 1 pmol/L I .25(OH),D3. with an ED,, of 0.3 pmol/ L. Further analysis indicated that virus production in cells treated with 1 .25(OH),D3 was specifically suppressed at least 60% by anti-TNF-n antibodies (Fig 5A) . which suggests a role for TNF-n in the action of 1.25(OH),D3. To rigorously prove that TNF-n was involved in the production of virus induced by 1 .25(OH),D3, culture supernatants ofcells incubated in the presence of 1.25(OH),D3 for variable times were analyzed for the presence of soluble TNF-a. As shown in Fig 5B. TNF-(U was detected in the culture supernatants of cells incubated for at least 2 to 3 days in the presence of 1 .25(OH),D3. The concentrations ofTNF-n detected were sufficiently elevated as to be able to induce viral production (see for comparison Fig 2) .
We also observed a small but measurable amount ofvirus produced by J,,-HL-60 cells cultured in the absence of any external stimulus. and the capacity ofthe unstimulated cells to produce virus decreased with the number of cell passages (Fig 6A) . Thus, no virus was detected in the supematant of cells continuously cultured for at least 3 months in the absence of any stimulus (Fig 6A) . However, these cells were able to respond to TNF-(U with the production of virus at levels equivalent to those observed with fresh cultures (Fig  6B) . Also, there was no change in the kinetics or the dose dependence of viral production induced by TNF-n. Maximal viral production was observed 24 hours after initiating the culture in response to 0.1 ng/mL of TNF-n (data not shown). We then tested the effect of anti-TNF-n antibodies on the production of virus by unstimulated cells. As shown in Fig 7A, anti-TNF-n antibodies suppressed production of virus by at least 60%. These observations prompted us to test for the presence ofTNF-n in the culture supernatants of cells cultured for different periods of time. As shown in Fig  7B. soluble TNF-n was observed in the culture supernatants of J,,-HL-60 cells maintained in culture for less than 2 months. Decreased levels of TNF-n were detected in the supernatant of cells maintained in continuous culture for longer periods of times (Fig 7B) . an observation that correlates well with the lack of viral production by these cells.
DISCUSSION
TNF and TPA are strongdifferentiatingagents for myelomonocytic leukemic cell lines>'43 Cytochemical differentiation into monocytes and macrophages is detectable after treatmentwithTNF-norTPA for3daysor24 hours,respecIn our studies. TNF-(U and TPA were found to enhance virus production in J2,-HL-60 cells within 12 hours. This result suggests that the effect of TNF-n on virus production may not be related solely to cell differentiation. Although it has been reported that HIV expression increases during monocyte maturation in association with an increase in expression of the transcription factor NFKB," it is clear that TNF-n or TPA may increase expression of NFKB without cell maturation. Expression of NFKB mRNA in HL-60 cells was enhanced 1 hour after exposure to TNF-(U or TPA." Our data indicate that TNF-n or TPA stimulates HIV production early in the differentiation process of myeloid precursors along the mononuclear phagocyte lineage.
1 ,25(OH),D3 also induces differentiation of immature HL-60 cells along the myelomonocytic p a t h~a y .~~,~~ Viral production induced by treatment with 1,25(OH),D3 required more than 48 hours, which suggests a role for cell differentiation in this process. This delay in viral production is consistent with our previous study indicating that virus elaboration was associated primarily with the mature, differentiated population of monocytic cells and was dissociated from cell pr~liferation.~~ Surprisingly, a substantial proportion (>60%) of the effect of 1,25(OH),D3 on HIV-1 production was blocked by TNF-a antibodies, and TNF-a viral production. These results strongly suggest that production of TNF-a is an important step in the induction of HIV-1 production after treatment of Jz,-HL-60 cells with
We also examined the effect of an antiviral agent, AZT, on viral production. AZT had no effect on HIV production in J,,-HL-60 cells. This result is consistent with the concept that AZT, a specific inhibitor of the viral reverse transcript a~e ,~' .~~ is not effective once the HIV provirus is integrated into host cell chromosomal DNA. Thus, our data suggest that treatment of the HIV-infected cells with TNF-a or 1 ,25(OH),D3 increases viral production via enhanced provirus transcription as opposed to viral replication.
Our data also indicate that the basal production of virus in cells not subjected to any external stimulus is because of an autocrine mechanism involving the intrinsic production of TNF-a by the infected cells. It was also possible to main-1,25(OH)zD3. For tain the J2,-HL-60 cells in continuous culture in a state of latent infection without production of virus; a state that was associated with absence of production of TNF-a by the infected cells. However, the cells maintained their sensitivity to induction of viral production by low concentrations of externally added TNF-a. These observations confirmed a central role for TNF in release from latency and subsequent virus production in a chronically HIV-infected cell line.
Two different TNF receptors have been described in mammalian cells, and both receptors can be activated by binding to TNF-a or TNF-&47,48 It has been shown that the mechanism of action of TNF-a on HIV production in infected cells involves the translocation-activation of the transcription factor N F K B . '~~~~.~~,~~,~~ Th e molecular basis of NFKB activation has been studied in detail and it is known that it involves a multiprotein complex and a cascade of phosphorylation-dephosphorylations.49 On the other hand, no clear information is available regarding the possible role of each individual TNF receptor in the signaling mechanism that leads to viral production. In addition, relatively little is known about the identity of other components involved in cell signaling through the TNF receptor(s). HL-60 cells are an exception to this rule, as in these cells it has been described that signaling through the TNF receptor involves the activation of a sphingomyelinase with concomitant production of ceramide and activation of a ceramide-dependent serine-threonine kina~e.~'.'~ We have shown that sphingomyelinase and ceramide cause activation of mitogen-activated protein kinase and NFKB in HL-60 suggesting that the sphingomyelin pathway is important for TNF signaling, at least in HL-60 cells. We recently developed direct evidence for HIV proviral activation in J,,-HL-60 cells induced by sphingomyelinase and ~eramide.'~ Although these studies illuminate a sphingomyelin-mediated TNF signaling pathway for HIV activation, the data at present are limited to HL-60 cells.
This pathway may also be activated by 1,25(OH),D3 in HL-60 cells, although with a different an observation consistent with our data indicating that TNF-a is involved in the production of virus induced by treatment of the J2,-HL-60 cells with 1,25(OH),D3. These findings are consistent with an autocrine role for TNF-a in the induction of HIV expression in the J,,-HL-60 cells, as has been shown in other cellular system^.^**^' Additional evidence for the existence of a sphingomyelin pathway and its involvement in the activation of NFKB has been recently pro~ided.'~,~' We have also obtained evidence indicating that a pathway able to recapitulate the basic characteristics of the mechanism of action of TNF (involving hydrolysis of sphingomyelin to ceramide and the production of TNF) is active in inducing viral production in the J2,-HL-60 cells (Rivas et al, submitted). The availability of the J2,-HL-60 cells offers a unique opportunity to identify intermediary molecules involved in the pathway that leads from TNF to activation and production of HIV under controlled experimental conditions. For personal use only. on October 3, 2017. by guest www.bloodjournal.org From
